Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
March 24, 2017
Primary Completion Date
August 7, 2017
Study Completion Date
August 7, 2017
Conditions
Healthy
Interventions
DRUG
Etanercept
50 mg/mL PFS and AI
Trial Locations (1)
Unknown
PRA Health Sciences, Groningen
All Listed Sponsors
lead
Samsung Bioepis Co., Ltd.
INDUSTRY
NCT03193203 - Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter